ProHealth health Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

New Lyme guidelines promote options and informed choice

Phases of clinical depression could affect treatment

“Worm pill” could ease autoimmune disease symptoms

Eating Baked or Broiled Fish Weekly Boosts Brain Health, Pitt Study Says

Preserving Cognitive Function with Aging

Scientists Look for Biomarkers to Improve Treatment of Painful Bladder Condition

9 Health Benefits of Cucumbers

New culprit identified in metabolic syndrome

Low vitamin D levels linked to increased risks after noncardiac surgery

Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel

 
Print Page
Email Article

ME/CFS Clinicians Challenge IOM Contract, Adopt Canadian Consensus Criteria

  [ 19 votes ]   [ Discuss This Article ]
www.ProHealth.com • September 23, 2013


Editor's Comment: The following letter represents a milestone in the ongoing struggle to define ME/CFS. Although the 2003 Canadian Consensus Criteria (CCC) have been endorsed by ME/CFS physicians and researchers worldwide as being more accurate and more practical than the CDC's Fukuda case definition, ME/CFS experts have not - until now - made a direct appeal to HHS to formally adopt the CCC. The 35 signatures on this letter represent the top researchers and clinicians in the field, speaking with one voice to demand that the HHS stop trying to bury this illness under a case definition that will undo a decade of scientific research.

Note: You can support this letter by signing the petition to change the definition - change the name.

An Open Letter to the Honorable Kathleen Sebelius, U.S. Secretary of Health and Human Services

September 23, 2013

Dear Secretary Sebelius,

We are writing as biomedical researchers and clinicians with expertise in the disease of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to inform you that we have reached a consensus on adopting the 2003 Canadian Consensus Criteria (CCC) as the case definition for this disease.

The 1994 International Case Definition (Fukuda et al, 1994), commonly known as the Fukuda definition, was the primary case definition for ME/CFS for almost two decades. However, in recent years expert researchers and clinicians have increasingly used the CCC, as they have recognized that the CCC is a more scientifically accurate description of the disease.

The CCC was developed by an international group of researchers and clinicians with significant expertise in ME research and treatment, and was published in a peer-reviewed journal in 2003 (Carruthers et al, Journal of Chronic Fatigue Syndrome, 2003). Unlike the Fukuda definition, the more up-to-date CCC incorporates the extensive scientific knowledge gained from decades of research. For example, the CCC requires the symptom of post-exertional malaise (PEM), which researchers, clinicians, and patients consider a hallmark of the disease, and which is not a mandatory symptom under the Fukuda definition. The CCC was endorsed in the Primer for Clinical Practitioners published by the International Association of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFSME). This organization is the major international professional organization concerned with research and patient care in ME/CFS.

The expert biomedical community will continue to refine and update the case definition as scientific knowledge advances; for example, this may include consideration of the 2011 ME International Consensus Criteria (Carruthers et al, Journal of Internal Medicine, 2011). As leading researchers and clinicians in the field, however, we are in agreement that there is sufficient evidence and experience to adopt the CCC now for research and clinical purposes, and that failure to do so will significantly impede research and harm patient care. This step will facilitate our efforts to define the biomarkers, which will be used to further refine the case definition in the future. 

We strongly urge the Department of Health and Human Services (HHS) to follow our lead by using the CCC as the sole case definition for ME/CFS in all of the Department’s activities related to this disease.

In addition, we strongly urge you to abandon efforts to reach out to groups such as the Institute of Medicine (IOM) that lack the needed expertise to develop “clinical diagnostic criteria” for ME/CFS. Since the expert ME/CFS scientific and medical community has developed and adopted a case definition for research and clinical purposes, this effort is unnecessary and would waste scarce taxpayer funds that would be much better directed toward funding research on this disease. Worse, this effort threatens to move ME/CFS science backward by engaging non-experts in the development of a case definition for a complex disease about which they are not knowledgeable.ME/CFS patients who have been disabled for decades by this devastating disease need to see the field move forward and there is no time to waste. We believe that our consensus decision on a case definition for this disease will jump start progress and lead to much more rapid advancement in research and care for ME/CFS patients. We look forward to this accelerated progress and stand ready to work with you to increase scientific understanding of the pathophysiology of this disease, educate medical professionals, develop more effective treatments, and eventually find a cure. 

Sincerely,

United States Signatories

Dharam V. Ablashi, DVN, MS, Dip Bact.

Scientific Director of HHV-6 Foundation

Co-founder of IACFS/ME

Santa Barbara, California

 

Lucinda Bateman, MD 

Director, Fatigue Consultation Clinic 

Executive Director, OFFER 

Salt Lake City, Utah

 

David S. Bell, MD, FAAP

Researcher and Clinician

Associate Professor of Pediatrics

State University of New York at Buffalo

Lyndonville, New York

 

Gordon Broderick, PhD 

Professor, Center for Psychological Studies 

Director, Clinical Systems Biology Lab

Institute for Neuro Immune Medicine, 

Nova Southeastern University 

Fort Lauderdale, Florida

 

Paul R. Cheney, MD, PhD

Director, The Cheney Clinic, PA

Asheville, North Carolina

 

John K.S. Chia, MD

Researcher and Clinician

President, EV Med Research

Lomita, California

 

Kenny L. De Meirleir, MD, PhD

Professor Emeritus Physiology and Medicine (Vrije Universiteit Brussel)

Medical Director, Whittemore-Peterson Institute

University of Nevada

Reno, Nevada

 

Derek Enlander, MD, MRCS, LRCP

Attending Physician

Mount Sinai Medical Center, New York

ME CFS Center, Mount Sinai School of Medicine

New York, New York

 

Mary Ann Fletcher, PhD

Schemel Professor of NeuroImmune Medicine

Institute for Neuro Immune Medicine

Nova Southeastern University

Fort Lauderdale, Florida

 

Ronald Glaser, PhD, FABMR

Director, Institute for Behavioral Medicine Research

Kathryn & Gilbert Mitchell Chair in Medicine

College of Medicine - Distinguished Professor

Professor, Molecular Virology, Immunology and Medical Genetics

Professor, Internal Medicine

Professor, Division of Environment Health Sciences, College of Public Health

Institute for Behavioral Medicine Research

Columbus, Ohio

 

Maureen Hanson, PhD

Liberty Hyde Bailey Professor

Department of Molecular Biology and Genetics

Cornell University

Ithaca, New York

 

Leonard A. Jason, PhD

Professor of Psychology

DePaul University

Chicago, Illinois

 

Nancy Klimas, MD

Director, Institute for Neuro Immune Medicine

Professor, Nova Southeastern University

Fort Lauderdale, Florida

 

Gudrun Lange, PhD

Clinical Neuropsychologist

Professor, Rutgers New Jersey Medical School

Newark, New Jersey

 

A. Martin Lerner, MD, MACP

Professor, Infectious Diseases

Oakland University William Beaumont School of Medicine

Emeritus Director, Infectious Diseases, Wayne State University School of Medicine

Master, American College of Physicians

Reviewer, Viral Diseases, Medical Letter

Beverly Hills, Michigan

 

Susan Levine, MD

Researcher and Clinician, Private Practice

New York, New York

Visiting Fellow, Cornell University

Ithaca, New York

 

Alan R. Light, PhD

Professor, Department of Anesthesiology and Department of Neurobiology and Anatomy

University of Utah

Salt Lake City, Utah

 

Kathleen C. Light, PhD

Researcher 

Professor, Department of Anesthesiology

University of Utah School of Medicine

Salt Lake City, Utah

 

Peter G. Medveczky, MD

Professor, Department of Molecular Medicine

College of Medicine

University of South Florida

Tampa, Florida

 

Judy A. Mikovits, PhD

Researcher, MAR Consulting, LLC

Carlsbad, California

 

Jose G. Montoya, MD, FACP, FIDSA 

Professor of Medicine

Division of Infectious Diseases and Geographic Medicine 

Stanford University School of Medicine 

Stanford, California

 

James M. Oleske, MD, MPH

François-Xavier Bagnoud Professor of Pediatrics

Director, Division of Pediatrics Allergy, Immunology & Infectious Diseases

Department of Pediatrics, Rutgers New Jersey Medical School

Newark, New Jersey

 

Martin L. Pall, PhD

Professor Emeritus of Biochemistry and Basic Medical Sciences

Washington State University

Portland, Oregon

 

Daniel Peterson, MD

Founder and President of Sierra Internal Medicine

Incline Village, Nevada

 

Richard Podell, MD, MPH

Clinical Professor, Department of Family Medicine

UMDNJ Robert Wood Johnson Medical School

New Brunswick, New Jersey

 

Irma Rey, MD

Clinician

Institute for Neuro Immune Medicine

Nova Southeastern University

Fort Lauderdale, Florida

 

Christopher R. Snell, PhD

Professor, Health, Exercise and Sport Sciences

University of the Pacific

Stockton, California

 

Connie Sol, MS, PhDc 

Clinical Exercise Physiologist 

Institute for Neuro Immune Medicine 

Nova Southeastern University 

Fort Lauderdale, Florida

 

Staci Stevens, MA

Exercise Physiologist

Founder, Workwell Foundation

Ripon, California

 

Rosemary A. Underhill, MB BS, MRCOG, FRCSE

Independent Researcher

Palm Coast, Florida

 

Marshall V. Williams, PhD

Professor, Departments of Molecular Virology, Immunology and Medical Genetics; Microbiology

The Ohio State University

Columbus, Ohio

 

International Signatories

 

Birgitta Evengard MD, PhD

Professor, Division Infectious Diseases

Umea University

Umea, Sweden

 

Sonya Marshall-Gradisnik, PhD 

Director, National Centre for Neuroimmunology and Emerging Diseases 

Griffith Health Institute 

Professor, Griffith University Parklands Gold Coast 

Queensland, AustraliaCharles Shepherd, MB BS

Honorary Medical Adviser to the ME Association

London, United Kingdom

 

Rosamund Vallings MNZM, MB BS

IACFS/ME Secretary 

Clinician, Howick Health and Medical Clinic

Auckland, New Zealand

 

Cc:

Dr. Howard Koh, Assistant Secretary for Health

Dr. Richard Kronick, Director, Agency for Healthcare Research and Quality

Dr. Thomas Frieden, Director, Centers for Disease Control and Prevention

Ms. Marilyn Tavenner, Administrator, Centers for Medicare and Medicaid Services

Dr. Margaret Hamburg, Commissioner, U.S. Food and Drug Administration

Dr. Mary Wakefield, Administrator, Health Resources and Services Administration

Dr. Francis Collins, Director, National Institutes of Health

Ms. Carolyn W. Colvin, Commissioner, Social Security Administration



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Your Next Order

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
Why Berries Offer a Rainbow of Health Benefits Why Berries Offer a Rainbow of Health Benefits
Sleep Like a Baby in Nature's Cradle Sleep Like a Baby in Nature's Cradle
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing